Author Interviews, Cognitive Issues, PLoS / 02.10.2013

Professor of Neuroscience Programme Director for BSc and MSci Pharmacology degrees School of Physiology & Pharmacology Medical and Veterinary Sciences University Walk University of Bristol Bristol, BS8 1TD.Neil V. Marrion, PhD Professor of Neuroscience Programme Director for BSc and MSci Pharmacology degrees School of Physiology & Pharmacology Medical and Veterinary Sciences University Walk University of Bristol Bristol, BS8 1TD. MedicalResearch.com: What are the main findings of the study? Dr. Marrion: We tested pravastatin and atorvostatin (two commonly prescribed statins) in rat learning and memory models.  Rats were treated daily with pravastatin (brand name - Pravachol) or atorvostatin (brand name - Lipitor) for 18 days. The rodents were tested in a simple learning task before, during and after treatment, where they had to learn where to find a food reward. On the last day of treatment and following one week withdrawal, the rats were also tested in a task which measures their ability to recognise a previously encountered object (recognition memory). The study’s findings showed that pravastatin tended to impair learning over the last few days of treatment although this effect was fully reversed once treatment ceased. However, in the novel object discrimination task, pravastatin impaired object recognition memory.  While no effects were observed for atorvostatin in either task. (more…)
Author Interviews, Nature, UT Southwestern, Weight Research / 01.10.2013

Philipp E. Scherer, PhD Professor, Department of Internal Medicine Gifford O. Touchstone Jr. and Randolph G. Touchstone Distinguished Chair in Diabetes Research Director, Touchstone Diabetes Center The University of Texas Southwestern Medical Center 5323 Harry Hines Blvd. Dallas, TX 75390-8549MedicalResearch.com Interview with: Philipp E. Scherer, PhD Professor, Department of Internal Medicine Director, Touchstone Diabetes Center The University of Texas Southwestern Medical Center Dallas, TX 75390-8549 MedicalResearch.com: What are the main findings of the study? Dr. Scherer: This is the first study that tracks the emergence of new fat cells in response to various physiological stimuli, such as high fat diet and cold exposure.  (more…)
Author Interviews, Global Health, Infections, Lancet / 01.10.2013

Prof Didier Pittet, MD, MS Director of the Infection Control Programme and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals, Geneva, SwitzerlandMedicalResearch.com Interview with : Prof Didier Pittet, MD, MS Director of the Infection Control Programme and WHO Collaborating Centre on Patient Safety, University of Geneva Hospitals, Geneva, Switzerland   MedicalResearch.com : What are the main findings of the study? Prof. Pittet: The main finding is that the WHO hand hygiene promotion strategy is feasible and sustainable across healthcare settings worldwide. For the first time, we have evidence of its feasibility and successful effects to improve hand hygiene in a variety of different geographical and income settings, with an even greater impact in low-/middle-income countries than in high-income countries. (more…)
Author Interviews, Heart Disease, Medical Imaging / 30.09.2013

Dr. Afshin Farzaneh-Far, M.D. University of Illinois at ChicagoMedicalResearch.com Interview with: Dr. Afshin Farzaneh-Far, M.D. University of Illinois at Chicago MedicalResearch.com: What are the main findings of the study? Answer: Traditionally SPECT MPI has been performed with adenosine which has a significant body of published prognostic data. Regadenoson is a selective A2A receptor agonist and is now the stress agent most widely used in the United States. Unlike adenosine, regadenoson is given as a bolus rather than as an infusion, simplifying the testing protocol and is better-tolerated. However, despite increasing use of regadenoson, there is very limited data on risk prediction using this agent. This study showed that the ability of SPECT MPI to predict heart attacks and death is the same for the new stress agent Regadenoson as it is for the old agent Adenosine. (more…)
Alzheimer's - Dementia, Author Interviews, Cognitive Issues / 30.09.2013

Teppo Särkämö PhD Institute of Behavioural Sciences PL 9 (Siltavuorenpenger 1A), 363 FI-00014, HELSINGIN YLIOPISTO FinlandMedicalResearch.com: Teppo Särkämö PhD Institute of Behavioural Sciences PL 9 (Siltavuorenpenger 1A), 363 FI-00014, HELSINGIN YLIOPISTO Finland MedicalResearch.com: What are the main findings of the study? Answer: We found that caregiver-implemented musical leisure activities, such as singing and music listening, are beneficial for elderly persons with mild-moderate dementia (PWD). Compared to standard care, regular singing and music listening improved mood, orientation level, episodic memory and to a lesser extent, also attention and executive function and general cognition. Singing also enhanced verbal working memory and caregiver well-being, whereas music listening had a positive effect on quality of life. (more…)
Author Interviews, Lung Cancer / 30.09.2013

MedicalResearch.com: Interview with: Dr.  Atul Butte, MD, PhDDr.  Atul Butte, MD, PhD and Julien Sage Ph. DJulien Sage PhD Departments of Pediatrics and Genetics Department of Internal Medicine, University of California Davis Cancer Center University of California Davis School of Medicine Sacramento, California MedicalResearch.com: What are the main findings of the study? Answer: A major finding of the study is the identification of first-generation anti-depressants as possible drugs effective against a lethal subtype of lung cancer, small cell lung cancer. A second important aspect of this work is the use of a bioinformatics-based drug repositioning pipeline developed by the Butte lab, which allowed us, when combined with advanced mouse models of lung cancer developed by the Sage lab, to identify a novel targeted therapy against SCLC and initiate a clinical trial in less than 2 years. (more…)
Author Interviews, Prostate Cancer / 26.09.2013

Robert G Bristow MD, PhD, FRCPC Clinician-Scientist, Ontario Cancer Institute/Princess Margaret Cancer Centre Professor, Depts. of Radiation Oncology and Medical Biophysics, University of Toronto Director, Core I - STTARR Innovation Facility Canadian Cancer Society Research Scientist MedicalResearch.com Interview with: Robert G Bristow MD, PhD, FRCPC Clinician-Scientist, Ontario Cancer Institute/Princess Margaret Cancer Centre Professor, Depts. of Radiation Oncology and Medical Biophysics, University of Toronto Director, Core I - STTARR Innovation Facility Canadian Cancer Society Research Scientist http://www.uhnres.utoronto.ca/researchers/profile.php?lookup=645 MedicalResearch.com: What are the main findings of the study? Dr. Bristow: We studied the more than 7 years of outcome of close to 250 patients with localized (intermediate risk) prostate cancer that received precision radiotherapy or surgery for cure. We found that up to one third of these patients fail initial radiotherapy or prostate surgery. By using a patient’s initial diagnostic core biopsy, we studied the DNA fingerprints of the tumors. We noticed a pattern in which the patients that had failed treatment had abnormal levels of breaks at sites within the chromosomes that are sensitive to DNA damage called, “common fragile sites” (CFS). These CFS break abnormalities have been linked to cancer in general and usually are associated with instability of the cell’s DNA-a phenomenon that is particularly associated with cancer. So patients who have unstable chromosomes are more likely to fail precision radiotherapy or surgery. (more…)
Author Interviews, Cancer Research, Diabetes, NYU, Weight Research / 26.09.2013

Niyati Parekh, PhD, RD Assistant Professor of Nutrition and Public Health, Director of Doctoral Program in Clinical Nutrition, Department of Nutrition, Food Studies and Public Health, Steinhardt School and Department of Population Health, NYU Langone School of Medicine, New York University 411 Lafayette Street NY. NY-10003.MedicalResearch.com Interview with: Niyati Parekh, PhD, RD Assistant Professor of Nutrition and Public Health, Director of Doctoral Program in Clinical Nutrition, Department of Nutrition, Food Studies and Public Health, Steinhardt School and Department of Population Health, NYU Langone School of Medicine, New York University 411 Lafayette Street NY. NY-10003. MedicalResearch.com: What are the main findings of the study? Dr. Parekh: The objective of the study was to investigate disturbances in blood glucose levels in relation to risk of obesity-related cancers. We observed an increased risk of obesity-related cancers, specifically colon cancer among persons with abnormal glucose values. These findings were stronger among persons who had this abnormality for longer duration (>10years). (more…)
Author Interviews, Pancreatic, Radiation Therapy / 26.09.2013

MedicalResearch.com Interview with: Dr. Raphael Yechieli Department of Radiation Oncology at Henry Ford Hospital in Detroit: MedicalResearch.com: What are the main findings of the study? Dr. Yechieli:  The main findings of the study are that elderly patients with pancreatic cancer who also have significant co-morbidities can still be safely and effectively treated with a short course of radiation treatment. Furthermore, the local control and survival data from our study are similar to previously published data, where patients were treated with more intense and longer courses of treatment. (more…)
Author Interviews, C. difficile, Infections, NEJM / 26.09.2013

MedicalResearch.com Interview with: David W. Eyre, B.M., B.Ch. Nuffield Department of Clinical Medicine University of Oxford National Institute for Health Research (NIHR) Oxford Biomedical Research Centre John Radcliffe Hospital MedicalResearch.com: What are the main findings of this study? Dr. Eyre: All cases of Clostridium difficile in Oxfordshire were studied over 3 years. Isolates were characterized by whole genome sequencing and the data was linked to hospital databases allowing epidemiological relationships between patients at the level of the hospital ward, hospital specialty, and post code to be identified. For comparison, similar information was also available for all other patients with and without diarrhea.  Preliminary work on the genetic diversity of Clostridium difficile within individuals and between individuals within discrete outbreaks allowed reliable interpretation of transmission events using genomic data. This allowed a complete reconstruction of the pattern of transmission between affected cases in Oxfordshire to be made. The findings were: 1. Unexpectedly few cases (13%) appear to be acquired from direct ward based contact with other symptomatic cases (these have previously been thought to be the main source of infections, and the focus of prevention efforts). Another 6% were associated with other hospital contact and 3% had plausible community contacts. 2. In 13% of cases potential donors were identified gnomically but no contact, within hospitals or the community, were identified. This suggests that the existence of other modes of transmission of Clostridium difficile. 3. The sources of Clostridium difficile infections were highly genetically diverse, with 45% of cases having a genetically distinct origin - suggesting a diverse reservoir of disease, not previously appreciated 4. During the 3 years of the study the rate of Clostridium difficile in Oxfordshire fell.  Any improvement in infection control techniques would be expected to reduce the incidence of cases caused by within hospital transmission. Surprisingly, similar rates of fall occurred in both in secondary cases (considered to be acquired from hospital associated symptomatic cases) and for primary cases (cases not associated with transmission from symptomatic cases). (more…)
Author Interviews, Cancer Research, Lancet, Prostate Cancer, Sloan Kettering / 26.09.2013

Dr. Ethan Basch MD Memorial Sloan-Kettering Cancer CenterMedicalResearch.com Interview with Dr. Ethan Basch MD Memorial Sloan-Kettering Cancer Center MedicalResearch.com: What are the main findings of the study? Dr. Basch: The primary clinical finding of this study is that treatment with abiraterone acetate delays the time until pain develops or worsens in men with advanced prostate cancer.  Furthermore, abiraterone delays the time until quality of life and functioning deteriorate, compared to placebo.  There is also a broader research finding of this study, which is that it is feasible to rigorously study the time until symptom progression in cancer clinical trials, which paves the way for future studies to use a similar approach. (more…)
Author Interviews, Hip Fractures, JAMA, Orthopedics / 25.09.2013

Sarah D. Berry MD MPH Institute for Aging Research, Hebrew Senior Life Boston, MassachusettsMedicalResearch.com Interview with: Sarah D. Berry MD MPH Institute for Aging Research, Hebrew Senior Life Boston, Massachusetts   MedicalResearch.com: What are the main findings of the study? Dr. Berry: Repeating a bone mineral density (BMD) screening test in 4 years provided little additional value beyond baseline BMD when assessing fracture risk. Also, the second BMD measure resulted in little change in risk classification that is commonly used in clinical management of osteoporosis. (more…)
Author Interviews, Cost of Health Care, JAMA, Medicare, Race/Ethnic Diversity, University of Michigan, Weight Research / 25.09.2013

Dr. Lauren Hersch Nicholas Ph.D Research Affiliate, Population Studies Center. Faculty Research Fellow, Survey Research Center University of MichiganMedicalResearch.com Interview Invitation Dr. Lauren Hersch Nicholas Ph.D Research Affiliate, Population Studies Center. Faculty Research Fellow, Survey Research Center University of Michigan MedicalResearch.com: What are the main findings of the study? Dr. Nicholas: We found that a Medicare policy designed to improve the safety of bariatric surgery was associated with 17% decline in the share of Medicare patients from minority groups receiving bariatric surgery. (more…)
Addiction, Author Interviews, Cocaine / 25.09.2013

MedicalResearch.com Interview with: Krishna Patel, M.S. Clinical Data Analyst Hartford Hospital|Institute of Living Olin Neuropsychiatry Research Center Hartford, CT-06106 MedicalResearch.com: What are the main findings of the study? Answer:  We looked at brain response to a monetary incentive delay (MID) task in current and former cocaine users compared to healthy controls using functional MRI. The task measures aspects of sensitivity to rewards and punishments. Current cocaine users showed abnormal under-activation in reward circuitry compared to healthy controls. In some of those regions former cocaine users (who had an average of 4years of abstinence from cocaine) also showed abnormalities. These former users also showed over-activation in the ventral tegmental area of the midbrain, (an important region containing dopamine cell bodies) compared to both healthy controls and current cocaine users. Current and former cocaine users also scored higher on specific impulsivity measures, compared to healthy controls. (more…)
Author Interviews, Kidney Disease / 25.09.2013

Renée L. Mulder, PhD Department of Pediatric Oncology Emma Children's Hospital / Academic Medical Center 1100 DD Amsterdam The NetherlandsMedicalResearch.com Interview with: Renée L. Mulder, PhD Department of Pediatric Oncology Emma Children's Hospital / Academic Medical Center 1100 DD Amsterdam The Netherlands MedicalResearch.com: What are the main findings of the study? Dr. Mulder: The glomerular function of childhood cancer survivors treated with nephrotoxic therapy declines very soon after treatment and does not recover. The glomerular function declines over time. This decline is comparable to survivors treated without nephrotoxic therapy. (more…)
Author Interviews, Genetic Research, Hip Fractures, Weight Research / 25.09.2013

Professor Tuan V. Nguyen Osteoporosis and Bone Biology Program Garvan Institute of Medical Research 384 Victoria Street, Darlinghurst NSW 2010 AustraliaMedicalResearch.com Interview with: Professor Tuan V. Nguyen Osteoporosis and Bone Biology Program Garvan Institute of Medical Research 384 Victoria Street, Darlinghurst NSW 2010 Australia MedicalResearch.com: What are the main findings of the study? Dr. Nguyen: We analyzed polymorphisms of the FTO (fat mass and obesity) gene in 934 elderly women of Caucasian background, and found that carriers of minor genotype (AA) of the SNP rs1121980 had a two-fold increase in the risk of hip fracture compared with carriers of major genotype (GG). Approximately 20% of women are carriers of the AA genotype. We estimate that about 17% of hip fracture cases could be attributed to the variation within the gene. (more…)
Author Interviews, Case Western, Exercise - Fitness, Heart Disease, UT Southwestern / 25.09.2013

Dr. Satyam Sarma MD Assistant Instructor, Cardiology University of Texas, Southwestern Medical Center Inst. for Exercise and Environmental Medicine 7232 Greenville Ave. Dallas TX 75231MedicalResearch.com Interview with: Dr. Satyam Sarma MD Assistant Instructor, Cardiology University of Texas, Southwestern Medical Center Inst. for Exercise and Environmental Medicine 7232 Greenville Ave. Dallas TX 75231 MedicalResearch.com: What are the main findings of the study? Dr. Sarma: The main findings of our study were that as we age or live a sedentary lifestyle, fat tends to accumulate in the muscle of the heart. The accumulation of myocardial lipids were linked to abnormalities in diastolic function. With increasing levels of fat, the left ventricle became less distensible and had impaired tissue relaxation. (more…)
Author Interviews, JAMA, Pediatrics / 25.09.2013

Spencer P. Bass, MD Twenty-First Century Professor of Family Medicine Director, International Family Medicine Clinic Department of Family Medicine University of Virginia, PO Box 800729 Charlottesville, VA  22908-072MedicalResearch.com Interview with: Fern R. Hauck, MD, MS Spencer P. Bass, MD Twenty-First Century Professor of Family Medicine Director, International Family Medicine Clinic Department of Family Medicine University of Virginia, PO Box 800729 Charlottesville, VA  22908-072 Co-author of "14 Ways to Protect Your Baby from SIDS" (www.parentingpress.com/sids.html) MedicalResearch.com: What are the main findings of the study? Dr. Hauck: We looked at data from the Infant Feeding Practices Study II, which followed mother from pregnancy through the first year of infant life. Mothers received several surveys that asked about infant feeding and bedsharing (sleeping with their infant in the same bed or other sleep surface). We found that mothers who bedshared for the longest time had the longest duration of breastfeeding compared with mothers who did not bedshare or bedshared for shorter times. Breastfeeding duration was also longer among mothers who were better educated, were white, had previously breastfed another child, had planned to breastfeed this baby, and had not returned to work in the first year after the baby was born. (more…)
Author Interviews, Weight Research / 25.09.2013

Christian Hampp PhD Division of Epidemiology-I, Office of Pharmacovigilance and Epidemiology Office of Surveillance and Epidemiology Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring, MarylandMedicalResearch.com Interview with: Christian Hampp PhD Division of Epidemiology-I, Office of Pharmacovigilance and Epidemiology Office of Surveillance and Epidemiology Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring, Maryland MedicalResearch.com: What are the main findings of the study? Dr. Hampp: We investigated the use of prescription antiobesity drugs, including duration of use, in the United States from 2002 through 2011.  We found that in 2011, approximately 2.74 million patients used antiobesity drugs, predominantly phentermine (2.43 million patients), while the use of prescription orlistat and sibutramine was relatively uncommon.  Eighty-five percent of antiobesity drug users were female, 62% were aged 17-44 years, and 4.5% had a body mass index of ≤24.9 kg/m2.  Duration of use was generally short and most patients only had one episode of antiobesity drug use during the observation period.  The longest episode of use was ≤30 days in 47- 58% of patients.  Approximately one quarter of patients used antiobesity drugs for longer than 90 days.  Only 1.3- 4.2% of antiobesity drug users used them for >1 year. (more…)
Heart Disease / 24.09.2013

MedicalResearch.com Interview with: Mackram Eleid, MD Division of Cardiovascular Diseases and Internal Medicine MedicalResearch.com: What are the main findings of the study? Dr. Eleid: Our study investigated the characteristics, outcomes and impact of aortic valve replacement in a large series of 1704 patients with severe aortic stenosis (aortic valve area < 1 cm2) and preserved ejection fraction (EF > 50%) according to the flow-gradient classification that incorporates both stroke volume index and mean aortic valve gradient.  The primary findings were that patients with low flow, low gradient AS have lower survival than other flow-gradient patterns (a 3.2-fold increase risk of mortality compared to normal flow, low gradient), and their survival is improved with aortic valve replacement.  Conversely, patients with normal flow and low gradient had a favorable survival with medical management, suggesting a less advanced stage of disease compared to the other groups.  Additionally, a novel observation from this study is that patients with low flow had a higher prevalence of atrial fibrillation and previous heart failure events compared to other groups. (more…)
Author Interviews, MRSA, Pediatrics / 23.09.2013

MedicalResearch.com Interview with: Dr. Martha Iwamoto, MD, MPH Centers for Disease Control and Prevention, Atlanta, Georgia; MedicalResearch.com: What are the main findings of the study? Dr. Iwamoto: We have been successful in decreasing invasive MRSA infections among infants younger than 3 months, mostly due to declines in hospital –onset infections in NICUs. However, more needs to be done among pediatric patients older than 3 months, especially those in the community settings and without recent healthcare exposures. (more…)
Author Interviews / 23.09.2013

Natasha Tidwell Graduate Research Assistant/Teaching Assistant Department of Psychology Texas A&M University - College Station 208 State Chemistry Building  Texas A&M UniversityMedicalResearch.com Interview with: Natasha Tidwell Graduate Research Assistant/Teaching Assistant Department of Psychology Texas A&M University - College Station 208 State Chemistry Building Texas A&M Universit MedicalResearch.com: What are the main findings of the study? Answer: Basically, two studies demonstrated that men’s tendency to engage in “off limits” sexual behaviors more than women is linked to sex differences in impulse, not control. In Study 1, we asked participants to reflect on previous times they succumbed to sexual temptations they felt were inappropriate some way. Based on their responses, we found that men both experienced stronger impulses and engaged in behavior based on these impulses more than women did. However, there was no reported difference in how much men and women exerted self-control. (more…)
Author Interviews, Pediatrics / 23.09.2013

MedicalResearch.com Interview with Selma Salihovic, Doctoral student Center for Developmental Research Örebro University MedicalResearch.com: What are the main findings of the study? Dr. Salihovic: Although previous research has examined the stability of psychopathic traits, our study offer a more nuanced perspective on development. Rather than asking whether psychopathic traits simply increase or decrease in adolescence, we asked about patterns of change for youths with different initial level of psychopathic traits. In this way, we could tease apart those youths with extreme levels from those with low and more transient levels, and follow their unique trajectories over four years. We could see that even among the youths with the highest levels there was a decreasing trend in two out of three core aspects of psychopathy. Although the degree of change was small, it was still a naturally occurring pattern for these youths, which raises the question whether an intervention designed to reduce these levels would have provided even a steeper decrease. (more…)
Author Interviews, Environmental Risks, Heart Disease / 22.09.2013

MedicalResearch.com Interview with: Dr Anoop Shah MBChB Cardiology Research fellow Centre of Cardiovascular sciences Chancellors Building University Of Edinburgh Little France Edinburgh MedicalResearch.com: What are the main findings of the study? Answer: Many studies have shown the effect of air pollution on cardiac mortality and myocardial infarction. Less studies have shown a similar effect on patients with heart failure. We therefore systemically reviewed and pooled data across 12 countries involving over 4 million patients with heart failure. We showed that air pollution has a close temporal association with either being hospitalized or dying from heart failure. Most of the effects of air pollution on patients with heart failure were acute. Most of the data that we analyzed came from developed countries across Europe and the USA. There was a  significant paucity of data from rapidly urbanizing nations such as India and China. (more…)
Alzheimer's - Dementia, Author Interviews, Cognitive Issues / 22.09.2013

Argonde van Harten From the Alzheimer Center School for Mental Health and Neurosciences, Maastricht University Medical Center, Maastricht, the Netherlands.MedicalResearch.com Interview Invitation Argonde van Harten From the Alzheimer Center School for Mental Health and Neurosciences, Maastricht University Medical Center, Maastricht, the Netherlands. MedicalResearch.com: What are the main findings of the study? Answer: We found cerebrospinal fluid biomarker evidence of preclinical Alzheimer's disease (AD) predicted cognitive decline in patients with subjective complaints. These patients have cognitive complaints, but are cognitively normal at baseline. Preclinical AD predicted decline in memory performance, executive functions and global cognition over time. Most patients, however, had no evidence of preclinical AD and their cogntive functions generally remained stable over two years. Their memory performance improved. (more…)
Author Interviews, Obstructive Sleep Apnea, Sleep Disorders / 21.09.2013

MedicalResearch.com Interview with: Marc L. Benton, MD, FCCP, FAASM Morristown Medical Center and Atlantic Sleep & Pulmonary Associates, 300 Madison Ave. Third Floor Madison, NJ 07940 MedicalResearch.com: What are the main findings of the study? Dr. Benton:  When compared to a group of matched controls, 12 male golfers who had moderate-severe obstructive sleep apnea syndrome (OSAS) demonstrated statistically significant improvement in their ability to play golf (as measured by changes in the Handicap Index, the standardized indicator of golfing performance) after undergoing CPAP treatment for their condition.  Treatment adherence among the group placed on CPAP was unusually high. (more…)
Author Interviews, Lancet, Smoking / 20.09.2013

Dr. Chris Bullen MBChB MPH PhD FAFPM FNZCPHM Director School of Population Health, The University of Auckland Private Bag 92019 Auckland 1142, New Zealand Co-Director of the NZ Tobacco Control Research Turanga: A national programme of research to inform rapid smoking prevalence reduction.MedicalResearch.com Interview with:

Dr. Chris Bullen MBChB MPH PhD FAFPM FNZCPHM Director School of Population Health, The University of Auckland Private Bag 92019 Auckland 1142, New Zealand Co-Director of the NZ Tobacco Control Research Turanga: A national programme of research to inform rapid smoking prevalence reduction. Web: http://www.turanga.org.nz/ MedicalResearch.com: What are the main findings of the study? Dr. Bullen:
  • E-cigarettes, with or without nicotine, were modestly effective at helping smokers to quit, with similar levels of abstinence as with nicotine patches, and few adverse events.
  • ?At 6 months, verified abstinence was 7·3% with nicotine e-cigarettes, 5·8% with patches, and 4·1% with placebo e-cigarettes. However, there was insufficient statistical power to conclude superiority of nicotine e-cigarettes to patches or to placebo e-cigarettes.
  • No significant differences in rates of adverse events occurrence were found between the groups.
  • E-cigarettes, like the vapes found at MagicVaporizers, were very popular throughout the trial, with almost 90% of users stating they would recommend them to a friend trying to quit smoking.
(more…)
Author Interviews, Breast Cancer, Cancer Research, Lancet / 20.09.2013

Prof Aron Goldhirsch Department of Medicine European Institute of Oncology Via Ripamonti 435, 20141 Milan, ItalyMedicalResearch.com Interview with: Prof Aron Goldhirsch Department of Medicine European Institute of Oncology Via Ripamonti 435, 20141 Milan, Italy MedicalResearch.com: What are the main findings of the study? Prof. Goldhirsch:  Two years of adjuvant trastuzumab after standard chemotherapy is not more effective than is 1 year of treatment with the drug for patients with HER2-positive early breast cancer. (more…)
Author Interviews, Breast Cancer, Lancet / 20.09.2013

Prof John R Yarnold Division of Radiotherapy and Imaging The Royal Marsden NHS Foundation Trust Sutton, Surrey SM2 5PT, UKMedicalResearch.com Interview with: Prof John R Yarnold Division of Radiotherapy and Imaging The Royal Marsden NHS Foundation Trust Sutton, Surrey SM2 5PT, UK   MedicalResearch.com: What are the main findings of the study? Prof. Yarnold: A 3-week schedule of curative post-operative radiotherapy for women with breast cancer involving 15 treatments (fractions) delivered Monday to Friday each week, is at least as safe and effective as historical schedules given over 5 or 6 weeks. In fact the 3-week schedule is gentler on the healthy tissues than earlier standard regimens. (more…)